Characteristics | No. of patients (NÂ =Â 156) (%) |
---|---|
Age (years, mean ± SD) | 52.8 ± 12.0 |
Histologic grade | |
 I | 13 (8.3) |
 II | 107 (68.6) |
 III | 36 (23.1) |
Tumor stage | |
 T1 | 77 (49.4) |
 T2 | 79 (50.6) |
Nodal stage | |
 Negative | 96 (61.5) |
 Positive | 60 (38.5) |
TNM stage | |
 I | 50 (32.1) |
 II | 106 (67.9) |
E-cad | |
 Negative/low | 27 (17.3) |
 Positive | 129 (82.7) |
ER | |
 Negative | 52 (33.3) |
 Positive | 104 (66.7) |
PR | |
 Negative | 82 (52.6) |
 Positive | 74 (47.4) |
HER2 | |
 Negative | 129 (82.7) |
 Positive | 27 (17.3) |
Ki67 | |
 Negative | 40 (25.6) |
 Positive | 116 (74.4) |
Molecular subtypes | |
 Luminal A | 30 (19.2) |
 Luminal B | 74 (47.4) |
 HER2-enriched | 14 (9.0) |
 TNBC | 38 (24.4) |